Studies have shown that while KRAS mutations are common in MM, the impact on survival varies, with some reports indicating that the activation of the MAPK pathway via the KRAS expression correlates with poor prognosis [9]. The gene discussed is KRAS; the disease is Miyoshi myopathy.